Ovid Therapeutics
OVID
#7730
Rank
NZ$0.75 B
Marketcap
NZ$4.02
Share price
-5.98%
Change (1 day)
61.30%
Change (1 year)

EPS for Ovid Therapeutics (OVID)

EPS in 2026 (TTM): NZ-$0.54

According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.57. In 2025 the company made an earnings per share (EPS) of NZ-$0.57 an increase over its 2024 EPS that were of NZ-$0.69.

EPS history for Ovid Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.54-4.86%
2025NZ-$0.57-18.42%
2024NZ-$0.69
2022NZ-$1.41-143.5%
2021NZ$3.24-226.43%
2020NZ-$2.56-11.39%
2019NZ-$2.89-25.47%
2018NZ-$3.88-24.06%
2017NZ-$5.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.47 335.48%๐Ÿ‡บ๐Ÿ‡ธ USA